Rejuveron in a CHF22.5M equity round backed by Korify, Gaingels,
21 December 2020
21 December 2020
Total investments received (USD): 100.31m
Round value (USD): 25.31m
Company: Rejuveron Life Sciences
Related deals
Synendos Therapeutics to raise CHF 20M in Series A financing led by Kurma Partners and Sunstone Life Science Ventures
Investments
11 November 2020
T3 Pharmaceuticals raised over CHF 25M from Boehringer Ingelheim Venture Fund (BIVF), Reference Capital SA, Wille Finance AG and private investors
Investments
22 July 2020
Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom